Sterile Injectable Drugs Market by Drug Type, Molecule Type, Therapeutic Application and End User - Global Industry Analysis and Forecast to 2023

2018-05-30 / 3800.00 / Pharma & Healthcare / 122 Pages

Description

Industry Outlook and Trend Analysis

The global sterile injectable drugs market was worth USD 281.15 billion in the year 2014 and is expected to reach approximately USD 504.40 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 6.71% during the forecast period. Injectable drug delivery is the presentation of a medication or medications to a patient with the assistance of a conveyance gadget, for example, a needle and syringe. It is basic that the injectable medication conveyance is clean. Clean injectable medications are generally planned in fluid shape and they permit the vehicle of medications straightforwardly into the body through coursing blood, despite the fact that they might be intended to transport the medication to a particular piece of the body.



Molecule Type Outlook and Trend Analysis

On the basis of Molecule Type, the global Sterile Injectable Drugs market is segmented Large Molecules and Small Molecules. Ascend in chronic infections over the world, particularly growth and diabetes; increment in concentrate of medication makers on innovative work of against disease drugs; quick endorsements by the FDA on account of clean injectable, combined with short endorsement courses of events for new medication for the treatment of malignancy are the key components boosting interest for clean injectable in the worldwide market.

Drug Type Outlook and Trend Analysis

On the basis of Drug Type, the global Sterile Injectable Drugs market is segmented into Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulin, Blood Factors, Peptide Antibiotics and Other drug types. Fabricate and development of clean injectable medication items are unpredictable and taken a toll arranged. Assembling and dealing with expenses of clean injectable drug products are nearly higher than customary dose shapes as the previous should be sanitized earlier or amid assembling. Besides, in the U.S., the FDA has forced stringent controls on the offices and hardware engaged with the fabricate of clean injectable drugs as these are exceptionally dangerous and irresistible.

Therapeutic Application Outlook and Trend Analysis

On the basis of Therapeutic Application, the worldwide Sterile Injectable Drugs market is segmented into Cancer, Diabetes, Cardiovascular Diseases, Central Nervous Systems, Infectious Disorders, Musculoskeletal and Others therapeutic applications. The cancer application section is overwhelming in the market, as a few medications for the treatment of disease are presently created in biologic frame. As far as course of organization, the clean injectable medications market can be sectioned into intravenous (IV), intramuscular (IM), subcutaneous (SC), intraperitoneal, and others.

End User Outlook and Trend Analysis

On the basis of End User, the global Sterile Injectable Drugs market is segmented into Hospitals, Drug Stores, Pharmacies and Online Pharmacies. The high demand for sterile injectables is likewise determined by countless manufacturers focusing on creating medications to treat tumor. Quick track administrative endorsements of sterile injectables and minimization of endorsement courses of events for creative medication improvement to cure tumor is in a roundabout way quickening the medication supply and is essentially filling development of the worldwide sterile injectables market.

Regional Outlook and Trend Analysis

The sterile injectable drugs market is expected to develop quickly in the rising nations in Asia Pacific and Latin America, attributable to high frequency of interminable sicknesses, for example, disease and diabetes in the nations, combined with ascend in consistence of patients as to novel advancements of treatment. Also, sedate producers are centered on the developing nations because of quick endorsements and lower rivalry in entering the market in these regions.

Competitive Insights

The key players of global sterile injectable drug market report incorporate Baxter International Inc., Sanofi, Pfizer Inc., GlaxoSmithKline plc., AstraZeneca, GILEAD SCIENCES, INC., Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc. and Nova Nordisk A/S.

The Sterile Injectable Drug Market is segmented as follows-

By Molecule Type:


Large Molecules
Small Molecules


By Drug Type:


Monoclonal Antibodies (mAbs)
Cytokines
Insulin
Peptide Hormones
Vaccines
Immunoglobulins
Blood Factors
Peptide Antibiotics
Others


By Therapeutic Application:


Cancer
Diabetes
Cardiovascular Diseases
Central Nervous Systems
Infectious Disorders
Musculoskeletal
Others


By End User:


Hospitals
Drug Stores
Pharmacies
Online Pharmacies


By Region


North America



U.S
Canada
Mexico



Europe



Germany
France
UK
Italy
Spain
Rest of Europe



Asia-Pacific



Japan
China
Australia
India
South Korea
Rest of Asia Pacific



Rest of the World



Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2014 to 2023`
What will be the industry market growth from 2014 to 2023`
What are the major drivers, restraints, opportunities, challenges and industry trends and their impact on the market forecast`
What are the major segments leading the market growth and why`
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition`

Table of Content

1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Sterile Injectable Drugs Market, By Drug Type
4.1. Introduction
4.2. Sterile Injectable Drugs Market Assessment and Forecast, By Drug Type, 2014-2023
4.3. Vaccines
4.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.4. Immunoglobulins
4.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.5. Blood Factors
4.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.6. Monoclonal Antibodies (mAbs)
4.6.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.7. Cytokines
4.7.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.8. Insulin
4.8.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.9. Peptide Hormones
4.9.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.10. Peptide Antibiotics
4.10.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
4.11. Other Drug Types
4.11.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5. Sterile Injectable Drugs Market, By Molecule Type
5.1. Introduction
5.2. Sterile Injectable Drugs Market Assessment and Forecast, By Molecule Type, 2014-2023
5.3. Small Molecules
5.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
5.4. Large Molecules
5.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6. Sterile Injectable Drugs Market, By Therapeutic Application
6.1. Introduction
6.2. Sterile Injectable Drugs Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
6.3. Infectious Disorders
6.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.4. Musculoskeletal
6.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.5. Cancer
6.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.6. Diabetes
6.6.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.7. Cardiovascular Diseases
6.7.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.8. Central Nervous Systems
6.8.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.9. Other Therapeutic Applications
6.9.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
7. Sterile Injectable Drugs Market, By End User
7.1. Introduction
7.2. Sterile Injectable Drugs Market Assessment and Forecast, By Molecule Type, 2014-2023
7.3. Drug Stores
7.3.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
7.4. Pharmacies
7.4.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
7.5. Hospitals
7.5.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
7.6. Online Pharmacies
7.6.1. Market Assessment and Forecast, By Region, 2014-2023 ($Million)
8. Sterile Injectable Drugs Market, By Region
8.1. Introduction
8.2. Sterile Injectable Drugs Market Assessment and Forecast, By Region, 2014-2023 ($Million)
8.3. North America
8.3.1. Market Assessment and Forecast, By Country, 2014-2023 ($Million)
8.3.2. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.3.3. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.3.4. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.3.5. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.3.5.1. U.S.
8.3.5.1.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.3.5.1.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.3.5.1.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.3.5.1.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.3.5.2. Canada
8.3.5.2.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.3.5.2.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.3.5.2.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.3.5.2.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.3.5.3. Mexico
8.3.5.3.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.3.5.3.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.3.5.3.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.3.5.3.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.4. Europe
8.4.1. Market Assessment and Forecast, By Country, 2014-2023 ($Million)
8.4.2. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.4.3. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.4.4. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.4.5. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.4.5.1. Germany
8.4.5.1.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.4.5.1.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.4.5.1.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.4.5.1.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.4.5.2. France
8.4.5.2.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.4.5.2.2. Market Assessment and Forecast, By Molecule Types, 2014-2023 ($Million)
8.4.5.2.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.4.5.2.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.4.5.3. UK
8.4.5.3.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.4.5.3.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.4.5.3.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.4.5.3.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.4.5.4. Italy
8.4.5.4.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.4.5.4.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.4.5.4.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.4.5.4.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.4.5.5. Spain
8.4.5.5.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.4.5.5.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.4.5.5.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.4.5.5.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.4.5.6. Rest of Europe
8.4.5.6.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.4.5.6.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.4.5.6.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.4.5.6.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5. Asia-Pacific
8.5.1. Market Assessment and Forecast, By Country, 2014-2023 ($Million)
8.5.2. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.5.3. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.5.4. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.5.5. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.5.1. Japan
8.5.5.1.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.5.5.1.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.5.5.1.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.5.5.1.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.5.2. China
8.5.5.2.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.5.5.2.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.5.5.2.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.5.5.2.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.5.3. Australia
8.5.5.3.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.5.5.3.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.5.5.3.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.5.5.3.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.5.4. India
8.5.5.4.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.5.5.4.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.5.5.4.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.5.5.4.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.5.5. South Korea
8.5.5.5.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.5.5.5.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.5.5.5.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.5.5.5.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.5.5.6. Rest of Asia-Pacific
8.5.5.6.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.5.5.6.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.5.5.6.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.5.5.6.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6. Rest of the World
8.6.1. Market Assessment and Forecast, By Country, 2014-2023 ($Million)
8.6.2. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.6.3. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.6.4. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.6.5. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.5.1. Brazil
8.6.5.1.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.6.5.1.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.6.5.1.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.6.5.1.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.5.2. Turkey
8.6.5.2.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.6.5.2.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.6.5.2.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.6.5.2.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.5.3. Saudi Arabia
8.6.5.3.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.6.5.3.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.6.5.3.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.6.5.3.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.5.4. South Africa
8.6.5.4.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.6.5.4.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.6.5.4.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.6.5.4.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.5.5. United Arab Emirates
8.6.5.5.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.6.5.5.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.6.5.5.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.6.5.5.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
8.6.5.6. Others
8.6.5.6.1. Market Assessment and Forecast, By Drug Type, 2014-2023 ($Million)
8.6.5.6.2. Market Assessment and Forecast, By Molecule Type, 2014-2023 ($Million)
8.6.5.6.3. Market Assessment and Forecast, By Therapeutic Application, 2014-2023 ($Million)
8.6.5.6.4. Market Assessment and Forecast, By End User, 2014-2023 ($Million)
9. Company Profiles
9.1. Baxter International Inc.
9.1.1. Business Overview
9.1.2. Product Portfolio
9.1.3. Strategic Developments
9.2. Sanofi
9.2.1. Business Overview
9.2.2. Product Portfolio
9.2.3. Strategic Developments
9.3. Pfizer Inc.
9.3.1. Business Overview
9.3.2. Product Portfolio
9.3.3. Strategic Developments
9.4. Novartis AG
9.4.1. Business Overview
9.4.2. Product Portfolio
9.4.3. Strategic Developments
9.5. Johnson & Johnson Services, Inc.
9.5.1. Business Overview
9.5.2. Product Portfolio
9.5.3. Strategic Developments
9.6. Nova Nordisk A/S
9.6.1. Business Overview
9.6.2. Product Portfolio
9.6.3. Strategic Developments
9.7. GlaxoSmithKline plc.
9.7.1. Business Overview
9.7.2. Product Portfolio
9.7.3. Strategic Developments
9.8. AstraZeneca
9.8.1. Business Overview
9.8.2. Product Portfolio
9.8.3. Strategic Developments
9.9. GILEAD SCIENCES, INC.
9.9.1. Business Overview
9.9.2. Product Portfolio
9.9.3. Strategic Developments
9.10. Merck & Co., Inc.
9.10.1. Business Overview
9.10.2. Product Portfolio
9.10.3.Strategic Developments


Table of Figures

Table 1.Sterile Injectable Drugs Market, By Drug Type ($Million), 2014-2023
Table 2.Vaccines Market, By Region ($Million), 2014-2023
Table 3.Immunoglobulins Market, By Region ($Million), 2014-2023
Table 4.Blood Factors Market, By Region ($Million), 2014-2023
Table 5.Monoclonal Antibodies (mAbs) Market, By Region ($Million), 2014-2023
Table 6.Cytokines Market, By Region ($Million), 2014-2023
Table 7.Insulin Market, By Region ($Million), 2014-2023
Table 8.Peptide Hormones Market, By Region ($Million), 2014-2023
Table 9.Peptide Antibiotics Market, By Region ($Million), 2014-2023
Table 10.Other Drug Types Market, By Region ($Million), 2014-2023
Table 11.Sterile Injectable Drugs Market, By Molecule Type ($Million), 2014-2023
Table 12.Small Molecules Market, By Region ($Million), 2014-2023
Table 13.Large Molecules Market, By Region ($Million), 2014-2023
Table 14.Sterile Injectable Drugs Market, By Therapeutic Application ($Million), 2014-2023
Table 15.Infectious Disorders Market, By Region ($Million), 2014-2023
Table 16.Musculoskeletal Market, By Region ($Million), 2014-2023
Table 17.Cancer Market, By Region ($Million), 2014-2023
Table 18.Diabetes Market, By Region ($Million), 2014-2023
Table 19.Cardiovascular Diseases Market, By Region ($Million), 2014-2023
Table 20.Central Nervous Systems Market, By Region ($Million), 2014-2023
Table 21.Other Therapeutic Applications Market, By Region ($Million), 2014-2023
Table 22.terile Injectable Drugs Market, By End User ($Million), 2014-2023
Table 23.Drug Stores Market, By Region ($Million), 2014-2023
Table 24.Pharmacies Market, By Region ($Million), 2014-2023
Table 25.Hospitals Market, By Region ($Million), 2014-2023
Table 26.Online Pharmacies Market, By Region ($Million), 2014-2023
Table 27.Sterile Injectable Drugs Market, By Region ($Million), 2014-2023
Table 29.North America Sterile Injectable Drugs Market, By Country, 2014-2023 ($Million)
Table 30.North America Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 31.North America Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 32.North America Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 33.North America Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 34.U.S. Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 35.U.S. Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 36.U.S. Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 37.U.S. Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 38.Canada Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 39.Canada Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 40.Canada Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 41.Canada Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 42.Mexico Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 43.Mexico Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 44.Mexico Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 45.Mecixo Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 46.Europe Sterile Injectable Drugs Market, By Country, 2014-2023 ($Million)
Table 47.Europe Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 48.Europe Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 49.Europe Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 50.Europe Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 51.Germany Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 52.Germany Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 53.Germany Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 54.Germany Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 55.France Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 56.France Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 57.France Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 58.France Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 59.UK Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 60.UK Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 61.UK Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 62.UK Market, By End User, 2014-2023 ($Million)
Table 63.Italy Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 64.Italy Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 65.Italy Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 66.Italy Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 67.Spain Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 68.Spain Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 69.Spain Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 70.Spain Market, By End User, 2014-2023 ($Million)
Table 71.Rest of Europe Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 72.Rest of Europe Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 73.Rest of Europe Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 74.Rest of Europe Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 75.Asia-Pacific Sterile Injectable Drugs Market, By Country, 2014-2023 ($Million)
Table 76.Asia-Pacific Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 77.Asia-Pacific Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 78.Asia-Pacific Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 79.Asia-Pacific Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 80.Japan Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 81.Japan Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 82.Japan Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 83.Japan Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 84.China Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 85.China Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 86.China Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 87.China Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 88.Australia Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 89.Australia Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 90.Australia Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 91.Australia Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 92.India Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 93.India Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 94.India Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 95.India Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 96.South Korea Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 97.South Korea Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 98.South Korea Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 99.South Korea Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 100.Rest of Asia-Pacific Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 101.Rest of Asia-Pacific Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 102.Rest of Asia-Pacific Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 103.Rest of Asia-Pacific Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 104.Rest of the World Sterile Injectable Drugs Market, By Country, 2014-2023 ($Million)
Table 105.Rest of the World Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 106.Rest of the World Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 107.Rest of the World Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 108.Rest of the World Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 109.Brazil Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 110.Brazil Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 109.Brazil Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 110.Brazil Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 111.Turkey Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 112.Turkey Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 113.Turkey Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 114.Turkey Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 115.Saudi Arabia Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 116.Saudi Arabia Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 117.Saudi Arabia Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 118.Saudi Arabia Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 119.South Africa Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 120.South Africa Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 121.South Africa Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 122.South Africa Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 123.United Arab Emirates Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 124.United Arab Emirates Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 125.United Arab Emirates Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 126.United Arab Emirates Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 127.Others Sterile Injectable Drugs Market, By Drug Type, 2014-2023 ($Million)
Table 128.Others Sterile Injectable Drugs Market, By Molecule Type, 2014-2023 ($Million)
Table 129.Others Sterile Injectable Drugs Market, By Therapeutic Application, 2014-2023 ($Million)
Table 130.Others Sterile Injectable Drugs Market, By End User, 2014-2023 ($Million)
Table 131.Baxter International Inc.: Key Strategic Developments, 2015-2017
Table 132.Sanofi: Key Strategic Developments, 2015-2017
Table 133.Pfizer Inc.: Key Strategic Developments, 2015-2017
Table 134.Novartis AG: Key Strategic Developments, 2015-2017
Table 135.Johnson & Johnson Services, Inc.: Key Strategic Developments, 2015-2017
Table 136.Nova Nordisk A/S: Key Strategic Developments, 2015-2017
Table 137.GlaxoSmithKline plc: Key Strategic Developments, 2015-2017
Table 138.AstraZeneca: Key Strategic Developments, 2015-2017
Table 139.GILEAD SCIENCES, INC.: Key Strategic Developments, 2015-2017
Table 140.Merck & Co., Inc.: Key Strategic Developments, 2015-2017

Request Sample

* mark fields are compulsory